Loading
The Searle Company Limited is a listed company. Its directors and officers file their transactions with PSX (SECP). 0 insiders has disclosed 6 filings since 25 October 2025.
Both sides are active: 5 purchases worth €902k and 1 sale worth €232, from 0 insiders and 0 insiders respectively. On balance, insiders were net buyers of €901k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. At €374k, the purchase published on 2 October 2026 is the largest of the period.
The latest purchase is recent: it was published 18 days ago, on 7 October 2026. Filings reach the PSX (SECP) feed a median of 2 days after the trade. Until a filing is published, the market cannot know about the trade.
Compared with its exchange (283 companies, median 3 filings), a count of 6 filings is above the norm.
Source: insider filings from PSX (SECP). Past trades are no guide to future returns.
· cache
25 of 47 declarations
The Searle Company Limited is a company operating in the XKAR market, specializing in the pharmaceutical sector. It focuses on the development and commercialization of innovative health products.